Effects of probiotics and antibiotics on the intestinal homeostasis in a computer controlled model of the large intestine

BMC Microbiology

Volumn 12, Issue , 2012, Pages

  Rehman, Ateequr ^a   Heinsen, Femke Anouska ^b   Koenen, Marjorie E ^c   Venema, Koen ^c   Knecht, Henrik ^b   Hellmig, Stephan ^d   Schreiber, Stefan ^d   Ott, Stephan J ^d  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

^c TNO   (Netherlands)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; CLINDAMYCIN; LACTIC ACID; PROBIOTIC AGENT; SHORT CHAIN FATTY ACID; ANTIINFECTIVE AGENT; VOLATILE FATTY ACID;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL STRAIN; BIFIDOBACTERIUM BREVE; BIFIDOBACTERIUM LONGUM; BIFIDOBACTERIUM LONGUM INFANTIS; COMPUTER MODEL; CONTROLLED STUDY; FECES MICROFLORA; HOMEOSTASIS; HUMAN; IN VITRO STUDY; INTESTINE FLORA; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS DELBRUECKII; LACTOBACILLUS PARACASEI; LACTOBACILLUS PLANTARUM; LARGE INTESTINE; METABOLISM; METABOLITE; NONHUMAN; NORMAL HUMAN; STREPTOCOCCUS THERMOPHILUS; BIOLOGICAL MODEL; BIOSYNTHESIS; CLOSTRIDIUM INFECTION; DRUG EFFECT; FEMALE; MALE; METAGENOME; MICROBIOLOGY; MIDDLE AGED;

BACTERIA (MICROORGANISMS); BIFIDOBACTERIUM BREVE; BIFIDOBACTERIUM LONGUM; BIFIDOBACTERIUM LONGUM BV. INFANTIS; CLOSTRIDIUM DIFFICILE; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS DELBRUECKII SUBSP. BULGARICUS; LACTOBACILLUS PARACASEI; LACTOBACILLUS PLANTARUM; STREPTOCOCCUS THERMOPHILUS;

AMMONIA; ANTI-BACTERIAL AGENTS; CLINDAMYCIN; CLOSTRIDIUM INFECTIONS; FATTY ACIDS, VOLATILE; FEMALE; HOMEOSTASIS; HUMANS; INTESTINE, LARGE; LACTIC ACID; MALE; METAGENOME; MIDDLE AGED; MODELS, BIOLOGICAL; PROBIOTICS;

EID: 84858837801     PISSN: None     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-12-47     Document Type: Article

References (30)

1. Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study. Wistrom J, et al. J Antimicrob Chemother 2001 47 1 43 50 10.1093/jac/47.1.43 11152430 (Pubitemid 32058754)
2. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. McDonald LC, Owings M, Jernigan DB, Emerg Infect Dis 2006 12 3 409 415 10.3201/eid1203.051064 16704777
3. Clostridium difficile infections among hospitalized children, United States, 1997-2006. Zilberberg MD, Tillotson GS, McDonald C, Emerg Infect Dis 2010 16 4 604 609 20350373
4. Clostridium difficile-more difficult than ever. Kelly CP, LaMont JT, N Engl J Med 2008 359 18 1932 1940 10.1056/NEJMra0707500 18971494
5. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. Hickson M, et al. BMJ 2007 335 7610 80 10.1136/bmj.39231.599815.55 17604300 (Pubitemid 47123282)
6. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. McFarland LV, Am J Gastroenterol 2006 101 4 812 822 10.1111/j.1572-0241.2006.00465.x 16635227
7. Evidence-based review of probiotics for antibiotic-associated diarrhea and Clostridium difficile infections. McFarland LV, Anaerobe 2009 15 6 274 280 10.1016/j.anaerobe.2009.09.002 19825425
8. Prevention of antibiotic-associated diarrhoea by a fermented probiotic milk drink. Wenus C, et al. Eur J Clin Nutr 2008 62 2 299 301 10.1038/sj.ejcn.1602718 17356555 (Pubitemid 351234268)
9. Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Corr S, et al. Proc Natl Acad Sci USA 2007 104 7617 7621 10.1073/pnas.0700440104 17456596 (Pubitemid 47185955)
10. Mechanisms of action of probiotics: recent advances. Ng S, et al. Inflamm Bowel Dis 2009 15 2 300 310 10.1002/ibd.20602 18626975
11. Mechanisms of action of probiotics in intestinal diseases. O'Hara A, Shanahan F, Scientific World Journal 2007 7 31 46 17221140 (Pubitemid 46104910)
12. Influences of probiotic bacteria on organic acid production by pig caecal bacteria in vitro. Sakata T, et al. Proc Nutr Soc 2003 62 73 80 10.1079/PNS2002211 12740061 (Pubitemid 36569811)
13. Probiotic preparations dose-dependently increase net production rates of organic acids and decrease that of ammonia by pig cecal bacteria in batch culture. Sakata T, et al. Dig Dis Sci 1999 44 7 1485 1493 10.1023/A: 1026624423767 10489936 (Pubitemid 29404315)
14. Mechanisms of probiotic actions-A review. Oelschlaeger TA, Int J Med Microbiol 2010 300 1 57 62 10.1016/j.ijmm.2009.08.005 19783474
15. Lactobacillus acidophilus 74-2 and Bifidobacterium animalis subsp lactis DGCC 420 modulate unspecific cellular immune response in healthy adults. Klein A, et al. Eur J Clin Nutr 2008 62 5 584 593 10.1038/sj.ejcn.1602761 17440520 (Pubitemid 351663397)
16. Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis. Kuhbacher T, et al. Gut 2006 55 6 833 841 10.1136/gut.2005.078303 16401690 (Pubitemid 43764555)
17. A computer-controlled system to simulate conditions of the large intestine with peristaltic mixing, water absorption and absorption of fermentation products. Minekus M, et al. Appl Microbiol Biotechnol 1999 53 1 108 114 10.1007/s002530051622 10645630 (Pubitemid 30120182)
18. Of the major phenolic acids formed during human microbial fermentation of tea, citrus, and soy flavonoid supplements, only 3,4-dihydroxyphenylacetic acid has antiproliferative activity. Gao K, et al. J Nutr 2006 136 1 52 57 16365058 (Pubitemid 43156484)
19. Metabolism of sinigrin (2-propenyl glucosinolate) by the human colonic microflora in a dynamic in vitro large-intestinal model. Krul C, et al. Carcinogenesis 2002 23 6 1009 1016 10.1093/carcin/23.6.1009 12082023 (Pubitemid 34752957)
20. TNO's in vitro large intestinal model: an excellent screening tool for functional food and pharmaceutical research. Venema K, et al. Ernährung/Nutrition 2000 24 12 558 564 22425188
21. Volatile fatty acids and alcohols determination in digestive contents, silage juice, bacterial culture and anaerobic fermenter contents. Jouany J, Sci Aliments 1982 2 131 144
22. The effect of various inulins and Clostridium difficile on the metabolic activity of the human colonic microbiota in vitro. Van Nuenen HMC, Meyer PD, Venema K, Microbial Ecology in Health and Disease 2003 15 2 3 10.1080/08910600310015547 (Pubitemid 37107734)
23. The effect of the undigested fraction of maize products on the activity and composition of the microbiota determined in a dynamic in vitro model of the human proximal large intestine. Maathuis A, et al. J Am Coll Nutr 2009 28 6 657 666 20516265
24. Starch-entrapped microspheres show a beneficial fermentation profile and decrease in potentially harmful bacteria during in vitro fermentation in faecal microbiota obtained from patients with inflammatory bowel disease. Rose DJ, et al. Br J Nutr 2010 103 10 1514 1524 10.1017/S0007114509993515 20021704
25. A statistical problem for inference to regulatory structure from associations of gene expression measurements with microarrays. Chu T, et al. Bioinformatics 2003 19 9 1147 1152 10.1093/bioinformatics/btg011 12801876 (Pubitemid 36790017)
26. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis. Miele E, et al. Am J Gastroenterol 2009 104 2 437 443 10.1038/ajg.2008.118 19174792
27. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Mimura T, et al. Gut 2004 53 1 108 114 10.1136/gut.53.1.108 14684584 (Pubitemid 38083018)
28. A randomized placebo-controlled comparison of 2 prebiotic/probiotic combinations in preterm infants: impact on weight gain, intestinal microbiota, and fecal short-chain fatty acids. Underwood MA, et al. J Pediatr Gastroenterol Nutr 2009 48 2 216 225 10.1097/MPG.0b013e31818de195 19179885
29. Impact of a synbiotic food on the gut microbial ecology and metabolic profiles. Vitali B, et al. BMC Microbiol 2010 10 4 10.1186/1471-2180-10-4 20055983
30. Regulation of Inflammation by Short Chain Fatty Acids. Vinolo M, et al. Nutrients 2011 3 10 858 876 10.3390/nu3100858 22254083